API and parent drug

Dinoprostone

CAS 363-24-6 · C20H32O5 · 15 related records

01API identity and structure

2D structure: Dinoprostone, CAS 363-24-6
Structure of Dinoprostone (CAS 363-24-6). LazyChem record. Source identity: PubChem CID 5280360. Confirm the identifiers before analytical use.Download structure image
API / medicine nameDinoprostone
CAS RN363-24-6
PubChem CID5280360
Molecular formulaC20H32O5
Molecular weight352.47 g/mol
IUPAC name(Z)-7-[(1R,2R,3R)-3-Hydroxy-2-[(E)-(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid
Defined stereocentres4
Unassigned stereocentres0
SMILESCCCCC[C@@H](/C=C/[C@H]1[C@@H](CC(=O)[C@@H]1C/C=C\CCCC(=O)O)O)O
InChINot listed
InChIKeyXEYBRNLFEZDVAW-ARSRFYASSA-N

02Stereochemistry

The published structure contains 4 defined and 0 unassigned tetrahedral stereocentres. The exact wedge-and-dash depiction is shown above.

Defined stereocentres42D structure
Unassigned stereocentres02D structure
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 16Before symmetry reduction

Published same-connectivity configurations

5 records

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

03Structural nitrosamine screen

Record-level resultNo candidate is published

No record-level structural candidate is currently published for this identity.

This result does not predict manufacturing conditions, formation, analytical findings or absence of risk. A process-specific assessment is required.

04India status for this compound

The result below applies only to this exact compound identity and CAS number.

NDPS / RCSNOT FOUND IN REVIEWED ENTRIESNo exact reviewed identity entry was found. Generic, class, analogue, salt and isomer provisions were not evaluated. Confirm the current official schedule before a regulatory decision.
SCOMETNOT FOUND IN REVIEWED CAS ENTRIESCAS 363-24-6 was not found in the reviewed exact-CAS mapping. Generic and analogue entries were not evaluated.

06Sources